Cargando…
P390: ALLO-HSCT OR CHEMOTHERAPY FOR B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA IN THE FIRST COMPLETE REMISSION: IMPACT OF MRD AND IKZF1
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429360/ http://dx.doi.org/10.1097/01.HS9.0000968468.18843.33 |
| _version_ | 1785090693405868032 |
|---|---|
| author | Deng, Shiyu Ou, Jiawang Cai, Zihong Huang, Zicong Xu, Xiuli Tang, Bingqing |
| author_facet | Deng, Shiyu Ou, Jiawang Cai, Zihong Huang, Zicong Xu, Xiuli Tang, Bingqing |
| author_sort | Deng, Shiyu |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10429360 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104293602023-08-17 P390: ALLO-HSCT OR CHEMOTHERAPY FOR B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA IN THE FIRST COMPLETE REMISSION: IMPACT OF MRD AND IKZF1 Deng, Shiyu Ou, Jiawang Cai, Zihong Huang, Zicong Xu, Xiuli Tang, Bingqing Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10429360/ http://dx.doi.org/10.1097/01.HS9.0000968468.18843.33 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Deng, Shiyu Ou, Jiawang Cai, Zihong Huang, Zicong Xu, Xiuli Tang, Bingqing P390: ALLO-HSCT OR CHEMOTHERAPY FOR B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA IN THE FIRST COMPLETE REMISSION: IMPACT OF MRD AND IKZF1 |
| title | P390: ALLO-HSCT OR CHEMOTHERAPY FOR B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA IN THE FIRST COMPLETE REMISSION: IMPACT OF MRD AND IKZF1 |
| title_full | P390: ALLO-HSCT OR CHEMOTHERAPY FOR B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA IN THE FIRST COMPLETE REMISSION: IMPACT OF MRD AND IKZF1 |
| title_fullStr | P390: ALLO-HSCT OR CHEMOTHERAPY FOR B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA IN THE FIRST COMPLETE REMISSION: IMPACT OF MRD AND IKZF1 |
| title_full_unstemmed | P390: ALLO-HSCT OR CHEMOTHERAPY FOR B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA IN THE FIRST COMPLETE REMISSION: IMPACT OF MRD AND IKZF1 |
| title_short | P390: ALLO-HSCT OR CHEMOTHERAPY FOR B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA IN THE FIRST COMPLETE REMISSION: IMPACT OF MRD AND IKZF1 |
| title_sort | p390: allo-hsct or chemotherapy for b-cell acute lymphoblastic leukemia in the first complete remission: impact of mrd and ikzf1 |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429360/ http://dx.doi.org/10.1097/01.HS9.0000968468.18843.33 |
| work_keys_str_mv | AT dengshiyu p390allohsctorchemotherapyforbcellacutelymphoblasticleukemiainthefirstcompleteremissionimpactofmrdandikzf1 AT oujiawang p390allohsctorchemotherapyforbcellacutelymphoblasticleukemiainthefirstcompleteremissionimpactofmrdandikzf1 AT caizihong p390allohsctorchemotherapyforbcellacutelymphoblasticleukemiainthefirstcompleteremissionimpactofmrdandikzf1 AT huangzicong p390allohsctorchemotherapyforbcellacutelymphoblasticleukemiainthefirstcompleteremissionimpactofmrdandikzf1 AT xuxiuli p390allohsctorchemotherapyforbcellacutelymphoblasticleukemiainthefirstcompleteremissionimpactofmrdandikzf1 AT tangbingqing p390allohsctorchemotherapyforbcellacutelymphoblasticleukemiainthefirstcompleteremissionimpactofmrdandikzf1 |